| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 10/04/1994 | CA1332223C Bone resorption |
| 09/29/1994 | WO1994021781A2 Extracellular signal-regulated kinase, sequences, and methods of production and use |
| 09/29/1994 | WO1994021671A1 Adipocyte differentiation inhibitor peptide and adipocyte differentiation inhibitor containing said peptide as active ingredient |
| 09/29/1994 | WO1994021667A1 Compound for inhibiting bone resorption and accelerating osteogenesis |
| 09/29/1994 | WO1994021266A1 The use of bisphosphonates in bone surgery |
| 09/29/1994 | WO1994015962A3 Derivatized calcitonins |
| 09/29/1994 | WO1994012880A3 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
| 09/28/1994 | EP0617030A1 Sulfonate and carbamate derivatives of 3-aroylbenzo (beta) thiophenes |
| 09/28/1994 | EP0616536A1 INHIBITING TRANSFORMING GROWTH FACTOR $g(b) TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX |
| 09/28/1994 | CN1092767A Spiro piperdines and homologs promote release of growth hormone |
| 09/28/1994 | CN1025998C 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines |
| 09/27/1994 | US5350758 Anticholesterol agents |
| 09/27/1994 | CA1332152C Pharmaceutical composition of dihydropyridine compound |
| 09/21/1994 | EP0615977A1 Spiro piperidines and homologs which promote release of growth hormone |
| 09/21/1994 | EP0615970A1 Benzene, pyridine and pyrimidine derivative |
| 09/21/1994 | EP0615549A1 Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase |
| 09/21/1994 | EP0425565B1 Silicon compounds in bone treatment |
| 09/21/1994 | CN1092418A Compounds |
| 09/21/1994 | CN1092415A Compounds |
| 09/20/1994 | US5348979 Method of promoting nitrogen retention in humans |
| 09/20/1994 | US5348974 Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders |
| 09/20/1994 | CA1332061C Benzofuranic compounds, process for their preparation, pharmaceutical compounds and cosmetics containing them, and their use |
| 09/20/1994 | CA1332044C Swine growth promotion |
| 09/15/1994 | WO1994020637A1 Fertility regulation with transforming growth factor beta |
| 09/15/1994 | WO1994020610A1 Variants of bile salt-stimulated lipase, dna molecules encoding them, and transgenic non-human mammals |
| 09/15/1994 | WO1994020532A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 09/15/1994 | WO1994020508A1 Phosphonic acid derivatives |
| 09/15/1994 | WO1994020492A1 Novel process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
| 09/15/1994 | WO1994020085A1 Methods and compositions for inhibition of angiogenesis |
| 09/15/1994 | WO1994011394A3 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 09/15/1994 | CA2156613A1 Fertility regulation with transforming growth factor beta |
| 09/14/1994 | EP0614974A2 Bone - associated transcription control factor-like protein and process for producing the same |
| 09/14/1994 | EP0614659A2 Pharmaceutical compositions in semisolid form and a device for administration thereof |
| 09/14/1994 | EP0614616A2 Composition for treating patients with hepatic disease |
| 09/14/1994 | EP0614456A1 1$g(a),24(S)-DIHYDROXY VITAMIN D 2?, ITS FORMATION AND USE |
| 09/14/1994 | EP0614374A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 09/14/1994 | EP0614358A1 Process and composition for the development of controlled release gemfibrozil dosage form |
| 09/14/1994 | EP0536151B1 Orthosubstituted biphenyl guanidine derivatives and antidiabetic or hypoglycaemic agents containing them |
| 09/14/1994 | EP0518960B1 Derivatives of n-phenyl glycinamide, their preparation and medicaments containing them |
| 09/14/1994 | CN1092071A Spiro piperidines and homologs which promote release of growth hormone |
| 09/13/1994 | US5346707 Food and feedstuff |
| 09/13/1994 | US5346697 Active oxygen scavenger |
| 09/13/1994 | CA1331991C Imidazo/2,1-b/benzothiazoles useful in the treatment of memory disorders and/or irritable conditions |
| 09/11/1994 | CA2118642A1 Bone-associated transcription control factor-like protein and process for producing the same |
| 09/10/1994 | CA2116947A1 Composition and method for treating patients with hepatic disease |
| 09/07/1994 | EP0613894A1 N-Heteroaryl-N'-phenylurea derivatives, their production and use |
| 09/07/1994 | EP0613472A1 10-acyl-dibenz(b,f) (1,4)-oxazepines and their thiazepines analo gues useful as prostaglandin antagonists |
| 09/07/1994 | EP0613376A1 Use of igf-1 |
| 09/07/1994 | EP0613373A1 Risedronate delayed-release compositions |
| 09/07/1994 | CN1091743A Pyrrole Derivative, Preparation of same and application of same in medical treatment |
| 09/07/1994 | CN1091741A Tartronic acids, their acetalic ethers and o-esters |
| 09/07/1994 | CN1091636A Medicaments |
| 09/07/1994 | CN1091634A Stabilized pharmaceutical compositions comprising an HMG-conreductase inhibitor compound |
| 09/07/1994 | CN1025855C Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
| 09/06/1994 | US5344991 Sulfonyl or sulfamyl derivatives for treatment of arthritis and pain |
| 09/06/1994 | US5344944 Cardiovascular insufficiency, increasing the contractive force of the heart |
| 09/06/1994 | US5344832 Administering dopamine agonist and prolactin stimulator |
| 09/06/1994 | US5344825 Methanediphosphonic acid formulations with ion exchangers |
| 09/06/1994 | US5344822 Methods useful in endotoxin prophylaxis and therapy |
| 09/01/1994 | WO1994019379A1 Polymeric compounds |
| 09/01/1994 | WO1994019354A1 Chemical compounds |
| 09/01/1994 | WO1994019335A1 Thiazole or imidazole derivatives as maillard reaction inhibitors |
| 09/01/1994 | WO1994019330A1 Heterocyclic-substituted alkyl amide acat inhibitors |
| 09/01/1994 | WO1994018985A1 USE OF 26,26,26,27,27,27-HEXAFLUORO-1α,25-DIHYDROXYCHOLECALCIFEROL FOR THE TREATMENT OF CALCIUM METABOLISM DISORDERS |
| 09/01/1994 | WO1994018967A1 Treatments for diseases characterized by neovascularization |
| 09/01/1994 | WO1994018959A1 Calcium receptor-active molecules |
| 09/01/1994 | CA2156186A1 Chemical compounds |
| 09/01/1994 | CA2153151A1 Polymeric compounds |
| 09/01/1994 | CA2118313A1 Treatments for diseases characterized by neovascularization |
| 08/31/1994 | EP0613006A1 Antibodies to cachectin and immunoassays |
| 08/31/1994 | EP0612763A1 Cyclic derivatives of angiopeptin, their preparation and their pharmaceutical compositions |
| 08/31/1994 | EP0612743A1 Oxazolidinedione derivatives, their production and use in lowering blood sugar and lipid levels |
| 08/31/1994 | EP0612741A1 Cyclic derivatives, medicaments containing them and process for their preparation |
| 08/31/1994 | EP0612723A1 Substituted benzoylguanidines, process for their preparation, their use as medicament, as inhibitor of the cellular Na+/H+ exchange or as diagnostic agent and medicament containing them |
| 08/31/1994 | EP0612522A1 Composition and method for reducing the risk of hypotension |
| 08/31/1994 | EP0612317A1 Substituted heterocycles as angiotensin ii antagonists |
| 08/31/1994 | EP0612246A1 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| 08/31/1994 | EP0612245A1 Use of alpha-ketoglutarate |
| 08/31/1994 | EP0612242A1 Methods and compositions utilizing pure s(+) isomer fluoxetine |
| 08/31/1994 | EP0612211A1 Alteration of rate and character of hair growth |
| 08/31/1994 | EP0549645B1 New 17- -oestradiol derivatives, a method of preparing them, and drugs containing them |
| 08/31/1994 | EP0496796B1 Method and compositions for inhibition of disorders associated with oxidative damage |
| 08/31/1994 | EP0474733B1 Antihyperlipidemic and antiatherosclerotic urea compounds |
| 08/31/1994 | CN1091285A Fatty acid treatment |
| 08/30/1994 | USRE34712 Pharmaceutically useful (+)-1-(3-dimethylaminopropyl)-1-(4'-fluorophenyl)-1,3-dihydroiso benzofuran-5-carbonitrile and non-toxic acid addition salts thereof |
| 08/30/1994 | US5342952 Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
| 08/30/1994 | US5342850 Therapeutical agent for diabetes without adverse effect; aldose reductase inhibitor |
| 08/30/1994 | US5342833 Useful in treatment of hyperproliferative skin diseases and sebaceous gland diseases |
| 08/30/1994 | CA1331757C 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
| 08/28/1994 | CA2116286A1 N-heteroaryl-n'-phenylurea derivatives, their production and use |
| 08/24/1994 | EP0611766A1 Polysubstituted 2-amido thiazoles derivatives, process for their preparation, pharmaceutical compositions and utilization for the preparation of a medicament |
| 08/24/1994 | EP0611765A1 2-(Imidazol-1-yl)-3-heteroarylpropylidene-aminoxyalkanoic acid derivatives |
| 08/24/1994 | EP0611756A2 Alcohol or aldehyde derivatives as cathepsin L inhibitor and bone resorption inhibitor |
| 08/24/1994 | EP0611660A2 Condensed 5-membered heterocycles, process for their preparation and medicines containing these compounds |
| 08/24/1994 | EP0611570A1 Use of chromic tripicolinate in the treatment of obese diabetic patients |
| 08/24/1994 | EP0506794B1 Novel vitamin d analogues |
| 08/24/1994 | EP0471761B1 Use of a GnRHanalog for the manufacture of a medicament for the treatment of motility disorders |
| 08/23/1994 | US5340813 Substituted aminoalkyl xanthine compounds |
| 08/23/1994 | US5340807 Tricyclic compounds and intermediates thereof |
| 08/23/1994 | US5340736 ATP-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting |